MKI67 and breast cancer: Konovalov et al. showed that dinuclear platinum(II) complexes with 1,6-naphthyridine-bridging ligand significantly decreased the percentage of Ki67+ 4T1 mouse breast cancer cells, as well as Ki67+ A549 human lung cells, in comparison to the untreated group [56].